Improved blood pressure control associated with a large-scale hypertension program
about
Updated national and international hypertension guidelines: a review of current recommendationsEconomics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic ReviewChallenges and opportunities for implementation of interventions to prevent and control CVD in low-resource settings: a report from CESCAS in ArgentinaEstimation of the Disease Burden Attributable to 11 Risk Factors in Hubei Province, China: A Comparative Risk AssessmentBig data analysis using modern statistical and machine learning methods in medicine.Big data and public health: navigating privacy laws to maximize potentialMethods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected.Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition ExamiDevelopment of a Smartphone-Enabled Hypertension and Diabetes Mellitus Management Package to Facilitate Evidence-Based Care Delivery in Primary Healthcare Facilities in India: The mPower Heart Project.Lipid, blood pressure and kidney update 2013.Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levels.Improved Blood Pressure Control to Reduce Cardiovascular Disease Morbidity and Mortality: The Standardized Hypertension Treatment and Prevention Project.Comprehensive approach for hypertension control in low-income populations: rationale and study design for the hypertension control program in Argentina.Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia.Trends in red blood cell transfusion and 30-day mortality among hospitalized patients.Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals.Factors related to clinical quality improvement for small practices using an EHRImplementing programs to improve hypertension management in typical practice settings: not as easy as it sounds.Racial and ethnic disparities among enrollees in Medicare Advantage plans.Maintenance of Certification Part IV Quality-Improvement Project for Hypertension Control: A Preliminary Retrospective Analysis.Cost-effectiveness of hypertension therapy according to 2014 guidelines.Determinants of hypertension in a young adult Ugandan population in epidemiological transition-the MEPI-CVD survey.Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.2014 Hypertension Guideline: Recommendation for a Change in Goal Systolic Blood PressureSimulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model.Management of hypertension and multiple risk factors to enhance cardiovascular health - a feasibility study in Singapore polyclinics.The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease.Effects of integrated chronic care models on hypertension outcomes and spending: a multi-town clustered randomized trial in China.Blood Pressure Visit Intensification Study in Treatment: Trial design.The spectrum of unhealthy drug use and quality of care for hypertension and diabetes: a longitudinal cohort studyThe Diabetes Telephone Study: Design and Challenges of a Pragmatic Cluster Randomized Trial to Improve Diabetic Peripheral Neuropathy Treatment.Population Care Management and Team-Based Approach to Reduce Racial Disparities among African Americans/Blacks with Hypertension.Elevated BP after AKI.Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events.Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.A public health approach to global management of hypertensionUsing Principles of Complex Adaptive Systems to Implement Secondary Prevention of Coronary Heart Disease in Primary Care.Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives.A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical Trial
P2860
Q26824589-16048168-9F68-46B9-9B8D-86EDE6E5DB57Q28083249-8572F3DE-5B8E-4416-8A36-774B0C04E880Q28087513-80CD04B7-46F9-4036-B299-EE86E90BA805Q28392824-93E29A74-6ECA-4977-A8DC-3FA11787C4A9Q30834684-D9058890-C413-45C2-8733-AE0F986DED83Q30902162-995E9ABF-6C10-4191-A742-FC34DF0C7C9CQ31090636-90A5DAE2-F25C-4F1C-A1CE-862C709431ABQ31115388-A57A7486-4596-4C9A-9A76-7DC6701CF191Q33168252-D500948B-E762-41C2-BC30-6D3BABA15B4AQ33451983-FC8CDDCB-20B8-44E8-9754-3CBBD4803170Q33574532-B8D0D30F-AA33-4F84-BA0E-B496927C57F1Q33813865-7EFFFC32-2315-4AE6-B849-E1FCDDEB59D3Q33813882-D2938C18-6C76-41B0-9A10-F8A3C7FF8867Q33940696-7CD4C1D0-8FE0-47F5-8158-55478C727457Q34070294-3F86E7C8-4C7F-4E1D-8D4C-D10CBC97C3D0Q34339186-8AF22C97-C25F-4EE4-A1B1-19036FC93C26Q34459136-A1103034-26A9-4BD8-943A-634E8977C9D0Q34623006-C5586837-DDD8-43D6-8BF6-FCCB38521696Q35221386-835602F3-3861-465C-80FE-485511D9260AQ35238299-70074F8F-E1CF-4DAB-95CB-0655F92EDC25Q35490037-4BA01E96-F6FB-4284-81C1-7D735C2FDA11Q35493852-630CB62F-89BD-4F9C-8B20-C2AA89882F10Q35758178-5EBAC54E-D8F0-4E6C-BA1B-DBCE98C6609BQ35803618-D8786932-1ECF-417E-969C-891F16F2D571Q35846497-E6B69B44-6FB9-466A-AD21-AFAC84EC7644Q35876683-76C25FA3-02AB-4003-8608-3908172E03DAQ36071553-504CCC97-ADA0-4E63-9BAE-B6AECA75F4FAQ36079293-D791ADF0-E016-4819-BC9C-8756611690F9Q36305146-F020CA3C-8725-4526-83B0-50CD933F02A8Q36385560-B1FEC343-68A2-4074-9CC0-DE94AE158256Q36406007-C5913425-C87C-4EE5-84EE-C69C0E96C02FQ36519853-CC0729E3-0F2C-4601-9EC8-EC6C7E8B6F96Q36520084-03E40F63-780F-4DBA-8F4C-51A56F3D0752Q36624663-3C312AD6-4302-4D5E-BCC1-962816935576Q36717551-AEFA87CB-665C-4662-9C97-751E61D5018EQ36757590-C858A671-AC2C-44E1-858D-C0F9025D56DDQ36794286-9059EBF9-BFE5-479C-A368-CA69403D644BQ36903552-D8A59BC2-AEA2-4A01-A6FF-A2852A15D3BFQ36970912-06DC41FC-A02C-4EBF-84FC-14D2BFE74F36Q37191351-248440D6-15BD-4509-B50F-E2E881FA0F1F
P2860
Improved blood pressure control associated with a large-scale hypertension program
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Improved blood pressure control associated with a large-scale hypertension program
@ast
Improved blood pressure control associated with a large-scale hypertension program
@en
Improved blood pressure control associated with a large-scale hypertension program
@nl
type
label
Improved blood pressure control associated with a large-scale hypertension program
@ast
Improved blood pressure control associated with a large-scale hypertension program
@en
Improved blood pressure control associated with a large-scale hypertension program
@nl
prefLabel
Improved blood pressure control associated with a large-scale hypertension program
@ast
Improved blood pressure control associated with a large-scale hypertension program
@en
Improved blood pressure control associated with a large-scale hypertension program
@nl
P2093
P2860
P356
P1476
Improved blood pressure control associated with a large-scale hypertension program
@en
P2093
Grace A Lee
Joseph D Young
Marc G Jaffe
Stephen Sidney
P2860
P304
P356
10.1001/JAMA.2013.108769
P407
P577
2013-08-01T00:00:00Z